Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Webinar: Protein Conformational Analysis Goes High-Throughput with xMAP Technology

Technique provides critical data for development of monoclonal antibodies and biosimilars

At a 2018 xMAP® Connect user group meeting, Xing Wang, President of Array Bridge, spoke about how his team is using xMAP Technology to streamline the development of new biologics and biosimilars for pharma/biotech scientists. The 30-minute presentation focuses on protein conformational analysis (PCA), a multiplex approach that replaces previous testing performed with ELISAs.

Continue Reading >

xMAP® Connect



xMAP® Connect is structured to grow your network and to enable you to discover the endless applications of xMAP Technology. During the program, you will hear from multiplex experts about cutting-edge methods development and innovative projects from the research and clinical spaces, as well as connect with fellow researchers, Luminex partners, and Luminex specialists onsite.

Watch more videos >

Luminex on Twitter

Previous #xMAPConnect events have attracted hundreds of attendees from dozens of countries around the world! Who wi…
h J R
Imagine if an assay existed that could quickly determine a person’s infection and vaccination history.…
h J R
Want to give your #PCA a boost? @xingwang5 and his colleagues at Array Bridge achieved 48x higher throughput using…
h J R

Latest News

October 1
Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay

September 26
Luminex Corporation to Present at the Cantor Global Healthcare Conference on
October 2, 2019

September 3
Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

July 31
Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend

July 11
Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019


October 2-6
Washington, D.C.

xMAP® Connect San Diego
October 3
San Diego, CA